43908 Search Results


sigapdh  (ATCC)
80
ATCC sigapdh
C12-200 LNPs are cytocompatible with TRPV1-expressing breast cancer cell line panel ( a ), rat primary DRG neurons ( b ), and MDA-MB-231 cells ( c ). Cells were incubated with LNPs containing 50 nM <t>siGAPDH</t> ( a ), 50 nM siTRPV1 ( b ), and the indicated concentrations of siGFP-LNPs ( c ) for 4 h. Untreated cells and cells treated with PEI (50 μg/mL) were used as negative and positive controls, respectively. Cell viability was determined 24 h post-transfection using a CellTiter-Glo luminescence viability assay, and the data were normalized to untreated cells. Data represents mean + SD ( n = 6)
Sigapdh, supplied by ATCC, used in various techniques. Bioz Stars score: 80/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/sigapdh/product/ATCC
Average 80 stars, based on 1 article reviews
sigapdh - by Bioz Stars, 2026-02
80/100 stars
  Buy from Supplier
micromonospora sp  (DSMZ)
93
DSMZ micromonospora sp
C12-200 LNPs are cytocompatible with TRPV1-expressing breast cancer cell line panel ( a ), rat primary DRG neurons ( b ), and MDA-MB-231 cells ( c ). Cells were incubated with LNPs containing 50 nM <t>siGAPDH</t> ( a ), 50 nM siTRPV1 ( b ), and the indicated concentrations of siGFP-LNPs ( c ) for 4 h. Untreated cells and cells treated with PEI (50 μg/mL) were used as negative and positive controls, respectively. Cell viability was determined 24 h post-transfection using a CellTiter-Glo luminescence viability assay, and the data were normalized to untreated cells. Data represents mean + SD ( n = 6)
Micromonospora Sp, supplied by DSMZ, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/micromonospora sp/product/DSMZ
Average 93 stars, based on 1 article reviews
micromonospora sp - by Bioz Stars, 2026-02
93/100 stars
  Buy from Supplier
nontargeting control sirna  (Addgene inc)
93
Addgene inc nontargeting control sirna
C12-200 LNPs are cytocompatible with TRPV1-expressing breast cancer cell line panel ( a ), rat primary DRG neurons ( b ), and MDA-MB-231 cells ( c ). Cells were incubated with LNPs containing 50 nM <t>siGAPDH</t> ( a ), 50 nM siTRPV1 ( b ), and the indicated concentrations of siGFP-LNPs ( c ) for 4 h. Untreated cells and cells treated with PEI (50 μg/mL) were used as negative and positive controls, respectively. Cell viability was determined 24 h post-transfection using a CellTiter-Glo luminescence viability assay, and the data were normalized to untreated cells. Data represents mean + SD ( n = 6)
Nontargeting Control Sirna, supplied by Addgene inc, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/nontargeting control sirna/product/Addgene inc
Average 93 stars, based on 1 article reviews
nontargeting control sirna - by Bioz Stars, 2026-02
93/100 stars
  Buy from Supplier

Image Search Results


C12-200 LNPs are cytocompatible with TRPV1-expressing breast cancer cell line panel ( a ), rat primary DRG neurons ( b ), and MDA-MB-231 cells ( c ). Cells were incubated with LNPs containing 50 nM siGAPDH ( a ), 50 nM siTRPV1 ( b ), and the indicated concentrations of siGFP-LNPs ( c ) for 4 h. Untreated cells and cells treated with PEI (50 μg/mL) were used as negative and positive controls, respectively. Cell viability was determined 24 h post-transfection using a CellTiter-Glo luminescence viability assay, and the data were normalized to untreated cells. Data represents mean + SD ( n = 6)

Journal: The AAPS Journal

Article Title: Development of Lipidoid Nanoparticles for siRNA Delivery to Neural Cells

doi: 10.1208/s12248-021-00653-2

Figure Lengend Snippet: C12-200 LNPs are cytocompatible with TRPV1-expressing breast cancer cell line panel ( a ), rat primary DRG neurons ( b ), and MDA-MB-231 cells ( c ). Cells were incubated with LNPs containing 50 nM siGAPDH ( a ), 50 nM siTRPV1 ( b ), and the indicated concentrations of siGFP-LNPs ( c ) for 4 h. Untreated cells and cells treated with PEI (50 μg/mL) were used as negative and positive controls, respectively. Cell viability was determined 24 h post-transfection using a CellTiter-Glo luminescence viability assay, and the data were normalized to untreated cells. Data represents mean + SD ( n = 6)

Article Snippet: Human cortical neuron cell line (HCN-2) (CRL-10742) and primary rat cortical neurons (RCN) (A10840-02) were purchased from ATCC (Manassas, VA) and Thermo Fisher Scientific (Frederick, MD) respectively. siGFP (AM4626), siGAPDH (Silencer Select GAPDH siRNA) (4390849), siTRPV1 (5′ GCGCAUCUUCUACUUCAACTT 3′, 3′ TTCGCGUAGAAGAUGAAGUUG 5′) [4390828 (Assay ID 554887)], and control, inverted siTRPV1 (5′ CAACUUCAUCUUCUACGCGTT 3′, 3′ TTGUUGAAGUAGAAGAUGCGC 5′) [4390828 (Assay ID 554886)] were procured from Thermo Fisher Scientific (Austin, TX).

Techniques: Expressing, Incubation, Transfection, Viability Assay